Lifecare AS announced that the European Patent Office (EPO) has notified that they will grant for a new patent to Lifecare. The patent relates to chemistry compositions and method for preparing the composition and use, specifically Lifecare's proprietary fluid composition reactive to glucose. This active fluid enables monitoring of glucose in Lifecares miniaturized sensor-technology, buy the means of osmotic pressure as the sensing principle, affecting and improving: sensor lifetime; due to high liquid stability measurement response asymmetry; because the viscosity is mainly independent of the glucose concentration, measurement sensitivity; due to optimal concentration and choice of compounds.

Lifecare applied for this patent in 2018 and after EPO's granting, it will strengthen the company's technology protection until 2037. Detecting glucose by the principle of osmotic pressure holds promise of a glucose sensingtechnology that is suitable for both miniaturization and long-term continuous monitoring in vivo without causing patient discomfort or reducing quality of life.